当前位置:首页 - 行情中心 - 澳洋健康(002172) - 财务分析 - 现金流量表

澳洋健康

(002172)

  

流通市值:27.93亿  总市值:27.95亿
流通股本:7.65亿   总股本:7.66亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金261,832,123.11,733,661,841.41,175,130,526.65812,109,565.37
  收到的税费返还--439,253.38439,253.38
  收到其他与经营活动有关的现金117,080,138.07197,483,825.67184,582,195.03177,237,242.06
  经营活动现金流入小计378,912,261.171,931,145,667.071,360,151,975.06989,786,060.81
  购买商品、接受劳务支付的现金182,888,244.41,327,720,345.48906,987,403.55660,890,477.91
  支付给职工以及为职工支付的现金86,665,281.88306,806,155.78240,803,380.41164,737,870.79
  支付的各项税费8,909,610.8150,760,741.5843,535,057.7631,349,142.82
  支付其他与经营活动有关的现金68,614,046.04233,238,039.95197,481,556.65187,936,403.81
  经营活动现金流出小计347,077,183.131,918,525,282.791,388,807,398.371,044,913,895.33
  经营活动产生的现金流量净额31,835,078.0412,620,384.28-28,655,423.31-55,127,834.52
二、投资活动产生的现金流量:
  收回投资收到的现金--2-
  处置固定资产、无形资产和其他长期资产收回的现金净额1,066.18252,358.2339,42039,120
  投资活动现金流入小计1,066.18252,358.2339,42239,120
  购建固定资产、无形资产和其他长期资产支付的现金5,003,935.9332,581,209.4829,543,595.4418,595,089.59
  投资支付的现金-300,0000-
  支付其他与投资活动有关的现金-10,760,566.52--
  投资活动现金流出小计5,003,935.9343,641,77629,543,595.4418,595,089.59
  投资活动产生的现金流量净额-5,002,869.75-43,389,417.77-29,504,173.44-18,555,969.59
三、筹资活动产生的现金流量:
  吸收投资收到的现金9,500330,000160,000-
  其中:子公司吸收少数股东投资收到的现金9,500330,000160,000-
  取得借款收到的现金539,095,523.181,141,610,962.66973,887,714.67573,556,493.11
  收到其他与筹资活动有关的现金13,600,00088,040,000132,412,000128,722,000
  筹资活动现金流入小计552,705,023.181,229,980,962.661,106,459,714.67702,278,493.11
  偿还债务支付的现金490,805,944.461,129,151,737.11888,525,222.22528,744,595.08
  分配股利、利润或偿付利息支付的现金8,255,257.4529,610,441.123,688,868.9315,650,514.04
  其中:子公司支付给少数股东的股利、利润-1,125,0001,125,0001,125,000
  支付其他与筹资活动有关的现金126,446,794.6146,581,010.58179,044,648.2123,930,978.89
  筹资活动现金流出小计625,507,996.511,305,343,188.791,091,258,739.35668,326,088.01
  筹资活动产生的现金流量净额-72,802,973.33-75,362,226.1315,200,975.3233,952,405.1
四、汇率变动对现金及现金等价物的影响-15,027.83-21,923.16-8,607.45-1,313.63
五、现金及现金等价物净增加额-45,985,792.87-106,153,182.78-42,967,228.88-39,732,712.64
  加:期初现金及现金等价物余额159,913,611.36266,066,794.14266,066,794.14266,066,794.14
  期末现金及现金等价物余额113,927,818.49159,913,611.36223,099,565.26226,334,081.5
补充资料:
  净利润-41,884,746.38-31,984,041.57
  资产减值准备-16,374,462.44-3,178,620.46
  固定资产和投资性房地产折旧-50,461,536.07-24,447,826.14
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-50,461,536.07-24,447,826.14
  无形资产摊销-4,335,422.75-2,136,935.65
  长期待摊费用摊销-1,637,814.88-1,021,958.47
  处置固定资产、无形资产和其他长期资产的损失--6,876.33--6,663.05
  固定资产报废损失-312,494.18-6,749.8
  公允价值变动损失-300,000--
  财务费用-29,567,043.36-15,078,522.87
  投资损失--2,154,386.5-350,293.32
  递延所得税--1,762,484.61--243,398.68
  其中:递延所得税资产减少--1,850,272.38--312,702.18
    递延所得税负债增加-87,787.77-69,303.5
  存货的减少-15,792,638.14-15,480,715.17
  经营性应收项目的减少--520,644,201.87--98,242,876.29
  经营性应付项目的增加-369,139,303.32--55,076,867.62
  现金的期末余额-159,913,611.36-226,334,081.5
  减:现金的期初余额-266,066,794.14-266,066,794.14
  现金及现金等价物的净增加额--106,153,182.78--39,732,712.64
公告日期2026-04-302026-03-312025-10-312025-08-27
审计意见(境内)标准无保留意见
TOP↑